Actively Recruiting
Preventive Effect of Perinatal Oral Probiotic Supplementation (POPS) on Neonatal Jaundice
Led by Chinese University of Hong Kong · Updated on 2024-05-20
94
Participants Needed
1
Research Sites
62 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This is a randomized double-blind placebo-controlled parallel group superiority clinical trial among 94 pregnant women (47 in each group) to investigate the effect of maternal perinatal probiotic supplementation on neonatal jaundice, breast milk microbiome, maternal stool, and infant fecal microbiome. Vivomixx®-probiotic product will be used as treatment and placebo as a control.
CONDITIONS
Official Title
Preventive Effect of Perinatal Oral Probiotic Supplementation (POPS) on Neonatal Jaundice
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Pregnant women aged 18 to 45 years old
- Gestational age between 28 and 34 weeks
- Normal singleton pregnancy
You will not qualify if you...
- Fetal abnormality
- Mothers using antibiotic medication during the study allocation
- Couples with glucose 6-phosphate dehydrogenase enzyme deficiency
- Couples with known rhesus or hemolytic disease history
- Plan to give birth at hospitals other than Prince of Wales Hospital
- Known breast disorders or any contraindication for breastfeeding
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Prince of Wales Hospital
Hong Kong, New Territories, Hong Kong, 0852
Actively Recruiting
Research Team
B
Bekalu K Alemu
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
QUADRUPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
PREVENTION
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here